Article Information
History
- October 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ella Hartenian1,†,
- Elliott M. Bernard1,†,
- Giulia Ammirati2,
- Sylvain Monnier3,
- Hubert B. Leloup3,
- Magalie Agustoni1,
- Lukas Bissegger4,
- José Carlos Santos1,
- Stefania Mari2,
- Christian Sieben5,
- Virginie Petrilli3,
- Daniel Müller2 and
- Petr Broz1,*
- 1Department of Immunobiology, University of Lausanne, Lausanne, Switzerland
- 2D-BSSE, ETH Zurich, Basel, Switzerland
- 3Centre de Recherche en Cancérologie de Lyon INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, France
- 4Department of Biomedicine, University of Basel, Basel, Switzerland
- 5Nanoscale Infection Biology Group, Helmholtz Centre for Infection Research and Institute for Genetics, Technische Universität Braunschweig, Braunschweig, Germany
- ↵*Corresponding author; Email: petr.broz{at}unil.ch
↵† These authors contributed equally
Posted October 29, 2024.
Ninjurin-1 mediated plasma membrane rupture is a two-step process requiring cell swelling
